DASH diet stayed within safe potassium bounds in adults on common blood pressure drugs
A potassium-rich DASH diet did not push serum potassium into dangerous territory in adults taking common antihypertensive medications, easing a long-standing practical concern in hypertension care. The 12-week findings are especially relevant for patients treated with ACE inhibitors or ARBs, drug classes that can impair potassium excretion and raise the risk of hyperkalemia.
In this cohort, the dietary shift did not produce the kind of biochemical drift that often forces clinicians to back away from fruit- and vegetable-forward eating plans. Instead, potassium levels held steady enough to suggest that whole-food potassium intake behaves differently from the rapid, concentrated potassium exposure seen with supplements or salt substitutes.
Potassium intake rose, but serum levels did not follow
Investigators analyzed 356 Black adults from the greater Boston area who were enrolled in the GoFresh and GoFreshRx trials. Seventy percent of participants were women, and the average age was 53 years. Participants either received DASH-patterned groceries or a stipend to buy foods that fit the plan, which delivered about 4,700 mg of potassium daily.
Baseline serum potassium was already in the normal range in both groups: 4.16 mmol/L in the grocery group and 4.18 mmol/L in the stipend group. After 12 weeks, there was no significant increase in potassium levels in either group.
That neutral laboratory response matters because clinicians often worry that dietary potassium and potassium-retaining medications will combine to produce a predictable rise in serum potassium. The kidneys, however, do not respond like a passive reservoir. In people with preserved renal function, they can increase potassium secretion enough to buffer the added dietary load, even when blood pressure medications alter renal handling of electrolytes.
Why food-based potassium behaves differently from supplements
Whole foods deliver potassium in a physiologic package that is absorbed more gradually than potassium chloride supplements. That slower exposure gives the kidneys more time to adapt, which may help explain why the dietary load in this study did not produce an unsafe rise in serum potassium.
David Rhee, MD, a board-certified cardiologist, said the findings reinforce the kidney’s ability to regulate water and electrolytes, even when medications affect renal physiology. He also noted that food-based potassium enters the bloodstream more slowly than potassium chloride supplements, a distinction with direct bedside relevance. A patient eating bananas, leafy greens, legumes, potatoes, avocados, and salmon is not receiving the same potassium challenge as someone taking a concentrated supplement.
Cheng-Han Chen, MD, a board-certified interventional cardiologist, said the data support greater confidence in recommending DASH-style eating patterns to patients taking ACE inhibitors, ARBs, or potassium-sparing diuretics, provided kidney function is not compromised. For many patients, the diet may improve blood pressure control without triggering the potassium problem that has traditionally made clinicians cautious.
Advanced kidney disease remains a different clinical problem
The reassuring signal stops short of extending to everyone with hypertension. Participants with stage 4 or 5 chronic kidney disease were not included, and the study also did not enroll people with higher-than-average baseline serum potassium. Those gaps are clinically important because impaired renal clearance is the main reason dietary potassium becomes dangerous.
In advanced chronic kidney disease, potassium excretion can fall enough that even ordinary dietary intake becomes risky, and intentionally increasing potassium may be unsafe. Chen cautioned that people with advanced chronic kidney disease or chronically high potassium should still avoid high-potassium diets. Rhee was even more direct: once kidney disease reaches stage 4 or 5, hyperkalemia can become a major hazard, and patients often need to reduce potassium intake rather than increase it.
A single dietary pattern cannot be treated as universally safe across all renal states.
How realistic is 4,700 mg of potassium a day?
The study’s potassium target is higher than what many people consume in daily life. Rhee said 4.7 grams of potassium is difficult to achieve, and that most adults take in about 2,000 to 3,000 mg per day. He suggested aiming for 3 to 5 grams when possible, using potassium-rich foods such as leafy greens, potatoes, legumes, bananas, avocados, and salmon.
That practical ceiling is important. Public health advice can sound abstract until it meets the reality of shopping, appetite, food budgets, and cultural eating patterns. A DASH diet built on real meals is easier to sustain than a numerical target on paper, and the study suggests that patients do not need to chase the exact upper-end potassium intake used in the protocol to benefit from a healthier eating pattern.
Rhee also emphasized that the best diet is one a patient can maintain, ideally with support from a nutritionist when the goal is to improve cardiovascular risk while keeping electrolytes stable.
What this means for everyday hypertension care
For many adults with hypertension, the study supports a more confident recommendation of potassium-rich foods within a DASH framework, even when treatment includes ACE inhibitors or ARBs. Clinicians have long balanced the blood-pressure benefits of potassium-rich eating against the fear of hyperkalemia. This trial suggests that, in patients without advanced kidney disease and without preexisting high potassium, that fear may be overstated when the potassium comes from food rather than supplements.
The result does not remove the need for monitoring. Patients taking several medications, or those with diabetes, kidney disease, or a history of electrolyte abnormalities, still need individualized advice and periodic laboratory follow-up. Hyperkalemia is not caused by one factor alone; it often emerges from the interaction of drugs, renal impairment, and baseline physiology.
Rhee said he already recommends potassium-rich fruits and vegetables to many patients with high blood pressure, with or without medication, and that these findings make him more confident in offering that advice. He also urged patients to discuss any major dietary change with their healthcare team, since many drugs beyond ACE inhibitors and ARBs can contribute to elevated potassium.
The study remains preliminary because the data were presented at a conference and have not yet appeared in a peer-reviewed journal. Its strongest contribution is a practical one: for adults with preserved kidney function, a DASH diet rich in potassium did not trigger dangerous serum potassium changes over 12 weeks. The unanswered question is how far that reassurance extends in patients with suboptimal kidney function, where the margin for electrolyte disturbance is much narrower.